Upgrade to SI Premium - Free Trial

Sage Therapeutics (SAGE) PT Raised to $189 at Goldman Sachs, Following Earnings

May 4, 2021 11:11 AM
Goldman Sachs analyst Salveen Richter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles